Telomerase claims resting almost entirely on one research lineage that nobody else has managed to replicate.
what it is
Epitalon is a four-amino-acid peptide — alanine, glutamic acid, aspartic acid, glycine — developed from Soviet and later Russian research into pineal gland extracts. The central claim attached to it is telomerase activation and, by extension, an effect on cellular ageing.
what the evidence shows
The published work comes overwhelmingly from a single research institute and its associated authors, including long-term observational reports in elderly cohorts. Independent replication by unaffiliated groups is scarce to absent, and much of the original literature is not readily available in English or was published in venues with limited external review.
Telomerase claims resting almost entirely on one research lineage that nobody else has managed to replicate.
what stays uncertain
Whether the core finding is real. A body of evidence produced by one group over decades, without outside replication, is a well-recognised warning pattern in biomedical research regardless of the field. Telomerase activation also has a complicated relationship with cancer biology that any serious claim would need to address.
the practical note
Epitalon sits in FDA Category 2. The gap between what this compound is claimed to do and what has been independently demonstrated is about as wide as it gets in this catalogue.